Following is a partial list of funded medical education and research projects supported by EvidenceBased.net

2016-2022 Doig GS, Simpson F, Ward C, Laviano A, Arthur C, Kerridge I, Angstmann K and Heighes P. Prophylactic early parenteral nutrition in patients undergoing hematopoietic cell transplantation: A multi-centre randomised controlled trial. $1,131,673.40

2013. Doig GS. Update of the Australian and New Zealand Bi-National Evidence-based guidelines for nutritional support in critical illness. Nestle Healthcare Nutrition, Australia, $78,100

2012-2016. Doig GS. Academic Audit of Current Nutrition Practices in ICUs throughout the World: A web-based quality improvement initiative.

Baxter Healthcare Pty Ltd. Sydney, $6,500

Baxter Healthcare Ltd. United States, $6,500

Nestle Healthcare Nutrition, South Africa, $6,500

2012-2014 Doig GS, Brereton J, Pollock C, Sweetman EA, Simpson F, Heighes, PT and Chesher D. Nephro-protective effects of L-amino acids in cardiac surgery patients: A pilot randomised controlled trial. North Shore Heart Research Foundation, $144,168

2012-2014. Doig GS. Nephro-protective effects of L-amino acids in cardiac surgery patients: An add-on study for a pilot randomised controlled trial. Sydney Medical School Cardiothoracic Surgery Research Grant Scheme, $27,195

2010-2014 Doig GS, Simpson F, Caterson I, Davies AR, McLean A, Bellomo R, Chesher D, Ferrie S, Harrigan P, Nair P and Nalos M. Management of refeeding syndrome in critical illness: An AuSPEN endorsed multicentre clinical trial. National Health & Medical Research Council Project Grant $1,308,800

2010-2013 Doig GS, Bellomo R, Davies AR, Simpson F, Reade M, Pollock C, Chesher D, Harrigan P, Devarajan, P, Botha J and Sweetman EA. Nephro-protective effects of L-amino acids in critically ill patients: A multi-centre randomised controlled trial. National Health & Medical Research Council Project Grant $829,300

2010-2012 Doig GS, Simpson F, Sweetman EA and Bellomo R. The effects of amino acid supplementation in critically ill patients at high risk of clinically significant renal dysfunction: Product support for a multi-centre randomised controlled trial. Baxter Health Care Pty Ltd, $142,920

2009-2010 Doig GS, Simpson F, Sweetman EA and Bellomo R. Background work in preparation for a multi-centre randomised controlled trial: The effects of amino acid supplementation in critically ill patients at high risk of clinically significant renal dysfunction. Baxter Health Care Pty Ltd, $20,000

2006-2010 Doig GS, Cooper DJ, Finfer SR, Simpson F, Solano T, Peake S and Davies A. Early parenteral nutrition vs. standard care in the critically ill patient: A Level I randomised controlled trial. National Health & Medical Research Council Project Grant, $1,812,750

2005-2009 Doig GS and Simpson F. Background work for an ANZICS CTG endorsed Level I randomised controlled trial: Early parenteral nutrition vs. standard care in the critically ill patient:

2003-2005 Doig GS, Finfer S, Simpson F, Dobb G, Mitchell I and Davies A. Developing and evaluating evidence-based guidelines for nutritional support in the intensive care unit: A cluster randomised trial. Australian and New Zealand Intensive Care Foundation, $548,000

2002 Doig GS. Development of a computer-based teaching model for the management of sepsis. Unrestricted educational grant from Eli Lilly Australia Pty. Limited, $11,000

2000-ongoing. Bourne R, Adolph S, Lee L and Doig GS. The Ontario Joint Replacement Waiting List Optimization Database. The Ontario Ministry of Health. $2,800,000 start-up plus $2,000,000 per year on-going.

2000 Doig GS. The development and use of a secure web site to facilitate a collaborative approach to utilization management at 14 regional hospitals in Ontario. Ontario Hospital Association and the Institute for Clinical Evaluative Sciences. $33,400

1999-2000 Doig GS, Martin CM and Webster G. A portal web site to promote evidence-based decision making. The Canadian Health Services Research Foundation Communications Infrastructure Development Fund. $18,000 ($32,500 in kind from London Health Sciences Centre Research Office).

1999 Doig GS. Development of a computer-based teaching model for the treatment of hypertensive crisis. Unrestricted educational grant from Bayer Healthcare Inc., $5,000

1998-1999 Doig GS and Sibbald WJ. Development of a website to promote evidence-based teaching and practice in the field of transfusion medicine. An unrestricted educational grant from Baxter Healthcare. $88,900

1998 Doig GS. Development of a computer-based teaching model for treatment of acute myocardial infarction. Unrestricted educational grant from Hoffmann-LaRoche Limited Canada, $5,000

1997 Doig GS. Use of the World Wide Web to facilitate the conduct of a Phase II FDA licensing trial. Eli Lilly Canada Inc. $23,500

1998-1999. Bayer Healthcare Inc. $60,000

1997-1998. HEALNet/RELAIS Clinical Theme $36,000

1996-1997. HEALNet/RELAIS Clinical Theme $32,060

1996. HEALNet/RELAIS Clinical Theme $ 7,750

1996-1997 Edmonds M , Bauer M, Lutfiyya H, Doig GS, Mahon J. Development and evaluation of the Vista 350 Telephone as a tool to communicate the results of home monitoring of diabetes mellitus to a central database: Clinical Data Module:

1996-1997. HEALNet/RELAIS Informatics Theme. $32,337

1996. Bell Innovations.$45,000

1996. HEALNet/RELAIS Informatics Theme $22,250

1996 Doig GS and Sibbald WJ. Development of a computer-based teaching model for nutritional management of the critically ill patient. Unrestricted educational grant from Sandoz Nutrition Canada, $5,000

1993-1994 Doig GS. Nosocomial infection surveillance in the ICU: A risk stratification approach. Department of Microbiology and Infection Control, Victoria Hospital Corp., $50,000